Global Mono Rapid Testing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Mono Rapid Testing Market Research Report 2024
Mono rapid testing is a type of point of care testing for the qualitative detection of mononucleosis heterophile antibodies in the whole blood. This test is only done for the diagnosis of infectious mononucleosis in the blood sample.
According to MRAResearch’s new survey, global Mono Rapid Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Mono Rapid Testing market research.
Key companies engaged in the Mono Rapid Testing industry include Cardinal Health, ELITech Group, Sekisui Diagnostics, Thermo Fisher Scientific, Cortez Diagnostic, Quidel, Jant Pharmacal, Abbott and Jant Pharmacal, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Mono Rapid Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Mono Rapid Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Mono Rapid Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Cardinal Health
ELITech Group
Sekisui Diagnostics
Thermo Fisher Scientific
Cortez Diagnostic
Quidel
Jant Pharmacal
Abbott
Jant Pharmacal
EKF Diagnostics
Verywell Health
Medline Industries
AccuBioTech
LabCorp
Segment by Type
Infectious Diseases Testing
Substance Abuse Testing
Hospitals
Clinic
Homecare Setting
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Mono Rapid Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Mono Rapid Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Mono Rapid Testing market research.
Key companies engaged in the Mono Rapid Testing industry include Cardinal Health, ELITech Group, Sekisui Diagnostics, Thermo Fisher Scientific, Cortez Diagnostic, Quidel, Jant Pharmacal, Abbott and Jant Pharmacal, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Mono Rapid Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Mono Rapid Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Mono Rapid Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Cardinal Health
ELITech Group
Sekisui Diagnostics
Thermo Fisher Scientific
Cortez Diagnostic
Quidel
Jant Pharmacal
Abbott
Jant Pharmacal
EKF Diagnostics
Verywell Health
Medline Industries
AccuBioTech
LabCorp
Segment by Type
Infectious Diseases Testing
Substance Abuse Testing
Segment by Application
Hospitals
Clinic
Homecare Setting
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Mono Rapid Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source